Echostar Technologies L.l.c.

Janssen Pharmaceutica Nv

Dish Technologies L.l.c.

Echostar Technologies Corporation

Echostar Corporation

Other

Echostar Technologies International Corporation

Echostar Satellite, LLC

David A Kummer

Rachel T Nishimura

Hariharan Venkatesan

Kevin Douglas Kreutter

Craig R Woods

Henry Gregg Martch

William Michael Beals

Steven Michael Casagrande

Ronald L Wolin

Aihua Wang

Maud J Urbanski

Xiaohua Xue

James Patrick Edwards

Kristi A Leonard

Umar Maharoof

Kent Barbay

Anne Fourie

Michael T Dugan

Danny Jean Minnick

Maxwell David Cummings

Steven D Goldberg

Mark Gomez

Kranti Kilaru

Jason Anguiano

Daniel L Rudolph

Kelly J McClure

John T Kennedy

Virginia M Tanis

Charles W Ergen

Nicholas Newell

Robert Drew Major

Edmund F Petruzzelli

John Paul

Germar Schaefer

William Norris Moran

Charlie William Zetterower

Connor L Martin

Daniel J Minnick

Adam C Morzos

Roger Lynch

Jennifer Diane Venable

Jianmei Wei

John Card, Ii

Gavin C Hirst

Wenying Chai

David Innes

David Christopher St John-Larkin

Kenneth Robert Hodge

Elizabeth G Fennema

J Kent Barbay

Amy Y Shih

Morgan Kirby

William Moore Jones

Mark W Jackson

Wendell R Blackman

Erik J Swenson

Anthony George Dower, Iii

Brent Tinker

S Craig Hemenway

Luke VanDuyn

Max Stephen Gratton

Christian Gege

Steven P Meduna

Thomas Steven Taylor

John M Keith

Christoph Steeneck

Olaf Kinzel

Bernard A McCarthy

Christopher Boyd Tirpak

Gerald Kleymann

Thomas Hoffmann

Dan J Minnick

Charlotte Pooley Deckhut

George C Lewis

Markus Wayne Jackson

Stefan McCarver

Alexander Valdes

Timothy B Rhorer

Steven Loskot

Alexander Raymond Rovira

Douglas Behenna

Taraneh Mirzadegan

Anand Menon

Joan M Pierce

Thomas T Taylor

Kerry P L Miller

Kelly Ganamet

Bernard Anthony Mccarthy

Joan Pierce

Kelly Lynn Ganamet

Steven M Casagrande

The present application discloses compounds having the following formula: or pharmaceutically acceptable salts thereof, wherein R, R, R, Rand Rare defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.

Imidazopyridazines as modulators of IL-17

Sultam compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with the KEAP1-Nrf2 interaction, such as inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

Inhibitors of KEAP1-Nrf2 protein-protein interaction

A mobile device includes a first display portion, a second display portion and a graphics processor. The first display portion is viewable while the second display portion is obscured when the mobile device is in a retracted configuration. Both display portions are viewable when the mobile device is in an expanded configuration. The graphics processor may be coupled to each display portion and configured to generate a first image for display on: the first display portion when the mobile device is in the retracted configuration; at least one of the display portions while the mobile device is in the expanded configuration; and at least one of the display portions while the mobile device transitions between the retracted configuration and the expanded configuration. The second display portion may be a flexible display material, such as an OLED display and with the first display portion may be a single sheet OLED display.

Mobile device with an expandable screen

The present invention comprises compounds of Formula I. wherein:R, R, R, R, R, R, R, Q, and Qare defined in the specification. The invention also comprises a method of treating or ameliorating a ROR-&#x3b3;-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating ROR&#x3b3;t activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

Phenyl and pyridinyl substituted imidazoles as modulators of ROR&#x3b3;T

The present invention comprises compounds of Formula I. wherein:R, Q, R, R, R, R, A, and Aare defined in the specification. The invention also comprises a method of treating or ameliorating a ROR-&#x3b3;-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating ROR&#x3b3;t activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

6-aminopyridin-3-yl pyrazoles as modulators of RORgT

The present invention comprises compounds of Formula I. wherein:R, R, R, R, R, R, R, and Q are defined in the specification. The invention also comprises a method of treating or ameliorating a ROR-&#x3b3;-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating ROR&#x3b3;t activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

Phenyl substituted pyrazoles as modulators of ROR&#x3b3;t

Techniques are disclosed for capturing, transcoding, and caching off-air programming at a location local to the consumer. According to certain embodiments, a device is provided that receives off-air (e.g., broadcast) and/or cable (e.g., ClearQAM) programming via one or more antennas and caches the programming in various streams having various bit rates for later viewing using, for example, Adaptive Bit Rate (ABR) streaming. Such a device can be incorporated in a larger system that can stream content via a data communication network (e.g., the Internet) and the device in a seamless manner. The device also can be controlled by a remote system via the data communication network, and further can be configured to stream content to a remote device via the data communication network.

Transcoding and caching for off air television programming delivery

Content receivers may simultaneously record multiple instances of content for multiple programming channels based on content provider instructions. Systems and methods utilize the content receivers to record these multiple instances from at least a single transponder. In some instances, multiple transponders may have a common control word so that content carried on each such transponder may be simultaneously received, decoded and recorded. Further, a single demodulator may be associated with multiple tuners, so that the single demodulator processes all content received from transponders with common control words and/or other encryption mechanisms.

Storing multiple instances of content

The present invention comprises compounds of Formula I. wherein:R, R, R, R, R, R, R, R, and Rare defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating ROR&#x3b3;t activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim

Alkyl linked quinolinyl modulators of ROR&#x3b3;t

A method for creating an announcement stream for a geographic region is provided. The method receives, at a designated computer system, characterizing metadata for a first audio/video stream; analyzes a second audio/video stream to obtain characterizing metadata for the second video stream; compares, with the computer system, the characterizing metadata for the first video stream to the characterizing metadata for the second video stream to generate offset data; and calculates timing information corresponding to segment boundaries for the second video stream using the offset data.

Geographically independent determination of segment boundaries within a video stream

Described are devices and methods for providing an extendable screen in a portable communications device. The device may include a first display, at least one second display, and a graphics processor, coupled to each of the first and second display. The graphics processor may be configured to perform computer executable instructions for configuring the communications device to facilitate the presenting of a first graphical image on a first display configured into a portable orientation display configuration, into an expanded orientation display configuration, where the first graphical image is presented on both the first display and the at least one second display, for into a second expanded orientation display configuration where the first graphical image is presented on one of the first display and the at least one second display, while a user interface control is presented on the other of the first display and the at least one second display.

Communications device with extendable screen

Measuring and tracking user interaction with a television receiver, such as a set top box or cable box. The television receiver may create and display a matrix code that includes temporal information, user identification information, geographic information, and/or a user selection. The matrix code may be captured by a matrix reading device and transmitted to a monitoring entity. Optionally, the matrix reading device may decode the matrix code and transmit associated data to the monitoring entity. The monitoring entity may use the code or data to track and distinguish between user interactions at different points in time.

Tracking user interaction from a receiving device

Growing community of inventors

Englewood, CO, United States of America

David A Kummer